Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson’s Disease Patients? A Systematic Review

Irene Katsaiti, John Nixon
  • Journal of Parkinson s Disease, June 2018, IOS Press
  • DOI: 10.3233/jpd-171225
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: